MedFirst Healthcare Services, Inc. (TPEX:4175)
Taiwan
· Delayed Price · Currency is TWD 67.40
+1.20 (1.81%)
May 14, 2025, 1:30 PM CST
TPEX:4175 Revenue
MedFirst Healthcare Services had revenue of 1.90B TWD in the quarter ending March 31, 2025, with 3.40% growth. This brings the company's revenue in the last twelve months to 7.80B, up 3.54% year-over-year. In the year 2024, MedFirst Healthcare Services had annual revenue of 7.73B with 3.87% growth.
Revenue (ttm)
7.80B
Revenue Growth
+3.54%
P/S Ratio
0.37
Revenue / Employee
n/a
Employees
n/a
Market Cap
2.85B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 7.73B | 287.90M | 3.87% |
| Dec 31, 2023 | 7.45B | 222.11M | 3.07% |
| Dec 31, 2022 | 7.22B | 683.79M | 10.46% |
| Dec 31, 2021 | 6.54B | 612.84M | 10.34% |
| Dec 31, 2020 | 5.93B | 622.47M | 11.73% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| PharmaEssentia | 11.34B |
| Caliway Biopharmaceuticals | 40.47M |
| Bora Pharmaceuticals Co., LTD. | 19.25B |
| Lotus Pharmaceutical | 19.12B |
| Polaris Group | 107.00M |
| Oneness Biotech | 117.93M |
| Pegavision | 6.69B |
| Lumosa Therapeutics | 43.59M |